Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NowPatient vs Vital Edge

NowPatient
Graded #217

Higher grade

vs+0.5
Vital Edge
Graded #229

Lower grade

The verdict

NowPatient takes it — 65.5/100 to 65/100, but only just.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda. Vital Edge is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVital Edge +2
35
37
Dose & formulationNowPatient +5
93
88
Clinical oversightEven
86
86
Labs & monitoringNowPatient +1
54
53
FulfillmentVital Edge +2
70
72
Contract termsEven
55
55
NowPatient · left barVital Edge · right bar

The numbers

MetricNowPatientVital Edge
WeighScore65.5/10065/100
GradeCC
Scorecard rank#217#229
Semaglutide$1,349/mo (brand Wegovy)$350/mo (compounded)
Tirzepatide$1,069/mo (brand Mounjaro, promotional rate)$450/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
NowPatient

Graded #217 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)
Vital Edge

Graded #229 · C

Strengths

  • Transparent flat monthly pricing published on-site — consult, medication, and shipping all included
  • Broad menu: compounded semaglutide/tirzepatide, compounded oral capsules from $199/mo, plus brand-name Ozempic, Wegovy, Mounjaro and Rybelsus
  • LegitScript-certified (seal #43281221)
  • Flat fee with no upcharge as your dose increases
  • Compounded oral GLP-1 capsules available for needle-free dosing

Where it loses points

  • Compounded injectable pricing ($350 semaglutide / $450 tirzepatide) runs above the lowest-cost telehealth options
  • No compounding pharmacy partner named on the site
  • No named medical director or prescribing clinicians
  • State availability not published — only a nationwide virtual-care claim
  • Small, locally-rooted operation with a limited public track record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard